Number of Patients, Male | 13 |
Number of Patients, Female | 10 |
Stage | All metastatic/advanced |
Age | Median (range): 59 (18–79) years |
Number of Prior Systemic Therapies | Median (range): 4 (1–10) |
Performance Status: ECOG |
0 — 4 1 — 19 2 — 3 — Unknown — |